HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CNO

CNO Financial Group, Inc. (NYSE)

Financial Services — Insurance - Life

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance and other insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individual consumers through phone, virtually, online, and face-to-face with agents. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single-premium deferred annuities; flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees, lesser degree, and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.

None 4 analysts
$52.07
+$1.09 (+2.14%)
Target: $49.50 (-4.9%)
Sign in to add CNO to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$4.86B
P/E Ratio (TTM)21.00
Forward P/E10.51
EPS (TTM)$2.48
Dividend Yield1.38%
Profit Margin5.44%
Revenue Growth2.50%
ROE9.76%
Debt/Equity172.19
Recommendation None
Analyst Target$49.50
Analysts4
Indexes NYSE

Technical Indicators

RSI (14)65.1
Beta0.84
SMA 20-
SMA 40-
52-Week High$53.03
52-Week Low$35.24
50-Day Avg$47.60
200-Day Avg$42.82
Avg Volume789.7K
Volume652.8K

Performance Analysis

NEUTRAL

CNO presents a mixed picture with both positive and negative indicators.

- Trading near its 52-week high ($53.03), which may indicate limited upside.
+ RSI at 65.1 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 2.5% year-over-year.
~ Wall Street consensus is "none" from 4 analysts.
- Average analyst target of $49.50 implies 4.9% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:03 UTC

Back to Screener Export Report